4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000011
Chief Medical Officer sold 1,641 shares at an average $10.56 ($17,336)
- Chief Medical Officer gave up 945 shares (to pay taxes)
- Chief Medical Officer acquired 28,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KREHER NERISSA Chief Medical Officer | 2023-03-01 | Grant or award | +28,400 | 43,916 | D: show line 1 in the form | ||
| KREHER NERISSA Chief Medical Officer | 2023-03-02 | Shares withheld for taxes | −945 | $11.60 | $10,958 | 42,971 | D: show line 2 in the form |
| KREHER NERISSA Chief Medical Officer | 2023-03-02 | Sale | −1,477 | $10.49 | $15,496 | 41,494 | D: show line 3 in the form |
| KREHER NERISSA Chief Medical Officer | 2023-03-02 | Sale | −164 | $11.22 | $1,841 | 41,330 | D: show line 4 in the form |
| Open-market sales · 1,641 sh · avg $10.56 · $17,336 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KREHER NERISSA Chief Medical Officer | 2023-03-01 | Grant or award · Stock Option (Right to Buy) | +43,000 | 43,000 | D: show line 5 in the form |
Loading xslF345X03/wf-form4_167787905815593.xml…